Kezar Life Sciences, Inc. — Director's Dealing 2020

Jan 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2020-01-12

Reporting Person: Economides Vassiliki (SVP, Strategy & External Aff.)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-12	Employee Stock Option (right to buy)	$3.29	A	62500	Acquired	2030-01-11	Common Stock (62500)	Direct

Footnotes

F1: One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 1, 2020, subject to the Reporting Person continuing to provide service through each such date.